Section 57
Chapter 56,707

Tumoral fibrosis effect on the radiation absorbed dose of (177) Lu-Tyr (3) -octreotate and (177) Lu-Tyr (3) -octreotate conjugated to gold nanoparticles

Azorín-Vega, E.P.; Zambrano-Ramírez, O.D.; Rojas-Calderón, E.L.; Ocampo-García, B.E.; Ferro-Flores, G.

Applied Radiation and Isotopes: Including Data Instrumentation and Methods for use in Agriculture Industry and Medicine 100: 96-100


ISSN/ISBN: 0969-8043
PMID: 25305748
DOI: 10.1016/j.apradiso.2014.09.005
Accession: 056706500

The aim of this work was to evaluate the tumoral fibrosis effect on the radiation absorbed dose of the radiopharmaceuticals (177)Lu-Tyr(3)-octreotate (monomeric) and (177)Lu-Tyr(3)-octreotate-gold nanoparticles (multimeric) using an experimental HeLa cells tumoral model and the Monte Carlo PENELOPE code. Experimental and computer micro-environment models with or without fibrosis were constructed. Results showed that fibrosis increases up to 33% the tumor radiation absorbed dose, although the major effect on the dose was produced by the type of radiopharmaceutical (112Gy-multimeric vs. 43Gy-monomeric).

PDF emailed within 0-6 h: $19.90